U.S. markets close in 2 hours 13 minutes

Orgenesis Inc. (ORGS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.9250-0.1250 (-6.10%)
As of 01:02PM EST. Market open.

Orgenesis Inc.

20271 Goldenrod Lane
Germantown, MD 20876
United States
480 659 6404

Full Time Employees151

Key Executives

NameTitlePayExercisedYear Born
Ms. Vered Caplan M.Sc.Chairperson of the Board, CEO & Pres3.98MN/A1969
Mr. Neil T. Reithinger CPACFO, Sec. & Treasurer239.67kN/A1970
Dr. Efrat Assa KunikChief Devel. Officer215.92kN/A1975
Prof. Sarah Ferber Ph.D.Founder & Chief Scientific OfficerN/AN/A1954
Mr. Evan FishmanChief Financial OfficerN/AN/AN/A
Dan SlonimCOO & GM of Orgenesis IsraelN/AN/AN/A
Dr. Shimon Hassin Ph.D.Chief Technology OfficerN/AN/AN/A
Ms. Osher Partok RheinischGen. Counsel & Compliance OfficerN/AN/AN/A
Mr. Vincent VandammeSr. VP of Quality StrategyN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.

Corporate Governance

Orgenesis Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.